These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12014965)

  • 1. Homodimeric tacrine congeners as acetylcholinesterase inhibitors.
    Hu MK; Wu LJ; Hsiao G; Yen MH
    J Med Chem; 2002 May; 45(11):2277-82. PubMed ID: 12014965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.
    Carlier PR; Chow ES; Han Y; Liu J; El Yazal J; Pang YP
    J Med Chem; 1999 Oct; 42(20):4225-31. PubMed ID: 10514292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE.
    Wang H; Carlier PR; Ho WL; Wu DC; Lee NT; Li CP; Pang YP; Han YF
    Neuroreport; 1999 Mar; 10(4):789-93. PubMed ID: 10208549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis.
    Carlier PR; Han YF; Chow ES; Li CP; Wang H; Lieu TX; Wong HS; Pang YP
    Bioorg Med Chem; 1999 Feb; 7(2):351-7. PubMed ID: 10218828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity.
    Butini S; Guarino E; Campiani G; Brindisi M; Coccone SS; Fiorini I; Novellino E; Belinskaya T; Saxena A; Gemma S
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5213-6. PubMed ID: 18786825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
    Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors].
    Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ
    Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
    Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
    Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Shao D; Zou C; Luo C; Tang X; Li Y
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.
    Hamulakova S; Janovec L; Hrabinova M; Kristian P; Kuca K; Banasova M; Imrich J
    Eur J Med Chem; 2012 Sep; 55():23-31. PubMed ID: 22818849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of tacrine-lophine hybrids via one-pot four component reaction and biological evaluation as acetyl- and butyrylcholinesterase inhibitors.
    da Costa JS; Lopes JP; Russowsky D; Petzhold CL; Borges AC; Ceschi MA; Konrath E; Batassini C; Lunardi PS; Gonçalves CA
    Eur J Med Chem; 2013 Apr; 62():556-63. PubMed ID: 23422935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.
    Savini L; Gaeta A; Fattorusso C; Catalanotti B; Campiani G; Chiasserini L; Pellerano C; Novellino E; McKissic D; Saxena A
    J Med Chem; 2003 Jan; 46(1):1-4. PubMed ID: 12502352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Cholinesterase Inhibitory Activity of N-Phosphorylated/ N-Tiophosphorylated Tacrine.
    Przybyłowska M; Inkielewicz-Stepniak I; Kowalski S; Dzierzbicka K; Demkowicz S; Daśko M
    Med Chem; 2020; 16(7):947-957. PubMed ID: 31309898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent Based on Tacrine for Theranostics.
    Meena VK; Chaturvedi S; Sharma RK; Mishra AK; Hazari PP
    Mol Pharm; 2019 Jun; 16(6):2296-2308. PubMed ID: 31059278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitors.
    Ozten O; Zengin Kurt B; Sonmez F; Dogan B; Durdagi S
    Bioorg Chem; 2021 Oct; 115():105225. PubMed ID: 34364052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.